Targeting platelet glycoprotein VI attenuates progressive ischemic brain damage before recanalization during middle cerebral artery occlusion in mice
Authors:
Open Access
- 1 October 2021
- journal article
- research article
- Published by Elsevier in Experimental Neurology
- Vol. 344, 113804
Abstract
No abstract availableKeywords
Funding Information
- Deutsche Forschungsgemeinschaft
This publication has 9 references indexed in Scilit:
- Platelets and lymphocytes drive progressive penumbral tissue loss during middle cerebral artery occlusion in miceJournal of Neuroinflammation, 2021
- CD84 Links T Cell and Platelet Activity in Cerebral Thrombo-Inflammation in Acute StrokeCirculation Research, 2020
- Thrombo-inflammation in acute ischaemic stroke — implications for treatmentNature Reviews Neurology, 2019
- Safety and Tolerability, Pharmacokinetics, and Pharmacodynamics of ACT017, an Antiplatelet GPVI (Glycoprotein VI) FabArteriosclerosis, Thrombosis, and Vascular Biology, 2019
- Targeting Platelet GPVI Plus rt-PA Administration but Not α2β1-Mediated Collagen Binding Protects against Ischemic Brain Damage in MiceInternational Journal of Molecular Sciences, 2019
- Neutrophils in Acute Stroke PathophysiologyStroke, 2019
- Collateral blood vessels in acute ischaemic stroke: a potential therapeutic targetThe Lancet Neurology, 2011
- Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal ResearchPLOS Biology, 2010
- Long-Term Antithrombotic Protection by in Vivo Depletion of Platelet Glycoprotein VI in MiceJournal of Experimental Medicine, 2001